HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC's Delayed Nano Inventory Reflects Notification Errors, Definitional Challenges

This article was originally published in The Rose Sheet

Executive Summary

A European Commission official says the long-awaited cosmetic nanomaterials inventory has been delayed due to notification inaccuracies, likely reflecting challenges associated with the "nanomaterial" definition enshrined in regulations. Nevertheless, the EC says it is nearing completion, and trade group Cosmetics Europe believes the catalogue could release this summer.

You may also be interested in...



EU Authorities Raising Nanomaterial Awareness With Cosmetics Inventory, 'Observatory'

If any of the 43 nanomaterials in the European Commission's long-awaited cosmetics inventory are surprises, compared with previous nano-notifications (or lack thereof), the ingredients could be subject to scrutiny and potential restrictions down the line. Separately, ECHA announced the launch of the EU Observatory for Nanomaterials to educate consumers, workers and industry pros on the nano landscape.

Existing Safety Principles Suffice For Nano-Cosmetics Evaluation – FDA

FDA maintains that the current framework for cosmetic safety assessment is sufficient to control potential risks associated with nano-engineered cosmetics. However, traditional testing methods may need to be modified or new strategies developed to account for nanomaterials’ unique properties and behavior, the agency says in final guidance issued June 24.

In Nanotech Metrics, Safety Should Trump Size, Experts Say

Evaluations of novel products based on nanotechnology should focus on safety and efficacy more than particle size, presenters at the FDLI annual conference say. The Project on Emerging Nanotechnologies is updating its product inventory to include more nanomaterial safety data.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109273

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel